ZHBIO(300653) 搜狐财经·2025-05-08 09:42Core Viewpoint - Zhenghai Biological's stock closed at 20.14 yuan, with a PE ratio of 29.99, marking a 15-day low, and a total market capitalization of 3.625 billion yuan [1] Company Summary - Zhenghai Biological focuses on the research, production, and sales of biological regenerative materials, with key products including oral repair membranes, absorbable dura mater patches, bone repair materials, skin repair membranes, surgical packing sponges, self-etching adhesives, active biological bone, dura mater patches, phosphoric acid etchants, and dental sealants [1] - The company was recognized as one of the top 50 new material leading enterprises in Shandong Province for 2023 [1] Financial Performance - For Q1 2025, the company reported revenue of 97.42 million yuan, a year-on-year increase of 8.68%, while net profit was 26.63 million yuan, reflecting a year-on-year decrease of 34.06%, with a gross profit margin of 80.96% [1] Industry Summary - The average PE ratio for the medical device industry is 49.20, with a median of 36.56, placing Zhenghai Biological at the 67th position in the industry ranking [2]